Phase I Evaluation of 131I-J591 Murine Monoclonal Antibody in Patients With Progressive Androgen-Independent Prostate Cancer.
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2009
At a glance
- Drugs J 591-radiolabelled (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 16 Jun 2009 Planned end date (Mar 2002) added as reported by ClinicalTrials.gov.
- 16 Jun 2009 Last checked against ClinicalTrials.gov record.
- 16 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.